Browse the evidence

In patients with Obstructive Sleep Apnea (OSA), the Apnea-Hypopnea Index (AHI) is not a significant independent predictor of cardiovascular events or all-cause mortality when adjusted for traditional risk factors, whereas specific physiological markers (time spent with oxygen saturation <90%, sleep time, awakenings, periodic leg movements, heart rate, and daytime sleepiness) are significant independent predictors.

If you have OSA, do not rely solely on your AHI score to assess your heart health risk. Ask your provider to evaluate other markers from your sleep study, specifically the time your oxygen levels drop, your heart rate during sleep, and the quality/quantity of your sleep, as these are stronger predictors of long-term cardiovascular events and mortality.

Loss of ovarian function (menopause) causes obesity and metabolic dysfunction primarily through reduced energy expenditure and increased adipose tissue inflammation, independent of increased food intake.

Postmenopausal weight gain is not just about eating more; your body burns fewer calories at rest. Focus on strategies that support metabolic rate and manage inflammation, rather than assuming the issue is solely caloric intake.

Ovariectomy induces visceral adipose tissue inflammation characterized by T-cell infiltration and M1 macrophage polarization, which contributes to insulin resistance.

Visceral fat becomes inflamed after menopause due to immune cell infiltration. This inflammation drives insulin resistance, suggesting anti-inflammatory strategies may be beneficial.

Hepatic insulin resistance promotes de novo lipogenesis (DNL) via upregulation of SREBP1c and ChREBP, contributing to liver fat accumulation.

Limiting carbohydrate intake, especially simple sugars, can reduce the substrate and signaling for DNL, thereby lowering liver fat production.

Among Chinese adults, the combined use of BMI, waist circumference, and waist-to-hip ratio reveals a high prevalence of overweight and obesity (approx. 70%) that increases with age until 60 and declines thereafter.

For Chinese adults, using just BMI might miss many cases of overweight or obesity. Combining BMI with waist circumference and waist-to-hip ratio gives a more accurate picture, showing that nearly 70% of adults have high adiposity. This risk increases with age until 60, then declines.

Chronic disease risk is determined by cumulative exposures throughout the life course, with fetal development and early childhood acting as critical periods for biological programming of adult metabolic and cardiovascular health.

Prevention of chronic disease must begin before birth. Public health strategies should focus on maternal nutrition, avoiding fetal growth restriction, and ensuring healthy early childhood growth to program lower risk for adult cardiovascular disease and diabetes.

Low birth weight (indicative of intra-uterine growth retardation) is associated with an increased risk of coronary heart disease, stroke, and diabetes in adulthood.

Pregnant women should be monitored for fetal growth restriction, as low birth weight is a marker for increased adult cardiovascular and metabolic risk.

Women exhibit lower biological aging and greater longevity than men, evidenced by molecular biomarkers, higher mitochondrial function, and longer telomeres, despite experiencing higher frailty and worse health outcomes at the end of life.

Biological aging is not identical between sexes. Women generally show molecular signs of slower aging (better mitochondrial function, longer telomeres) and live longer, but often suffer more from frailty and chronic disease in old age. Men may maintain physical function longer but face higher risks of early mortality and specific diseases. Personalized health strategies should account for these inherent biological differences rather than applying a one-size-fits-all approach to aging.

Estrogen and other sex hormones play a protective role in mitochondrial function and aging, with women showing higher mitochondrial gene expression and activity compared to men.

Hormones, particularly estrogen, significantly impact how your cells produce energy and age. Women naturally have more active mitochondria, which contributes to their longer lifespan. As estrogen levels drop after menopause, this protective effect diminishes, potentially accelerating certain aspects of aging. Maintaining metabolic health becomes crucial during this transition.

Telomere length is sexually dimorphic, with women having longer telomeres than men from birth, which may contribute to their longer lifespan, although the causal relationship is complex and influenced by genetics and stress.

Women naturally have longer telomeres, a marker of cellular aging, which may help explain their longer lifespan. However, telomeres shorten due to stress, genetics, and lifestyle factors. While you cannot change your sex, managing stress and maintaining a healthy lifestyle can help preserve telomere length.

Higher leg fat mass is independently associated with lower fasting and postload glucose levels, suggesting a protective effect against disturbed glucose metabolism.

Do not strive to lose fat from your legs if you have high trunk fat. Leg fat may help protect your blood sugar levels. Focus weight loss efforts on the abdominal area.

Intracerebroventricular infusion of leptin attenuates the rewarding effect of lateral hypothalamic stimulation in brain regions sensitive to chronic food restriction, while enhancing it in insensitive regions.

Leptin, a hormone from fat cells, doesn't just suppress appetite; it actively changes how rewarding certain brain activities feel. In areas linked to feeding, leptin makes stimulation less rewarding, potentially reducing the drive to eat. However, in other brain areas, it makes stimulation more rewarding, possibly encouraging other behaviors. This suggests leptin helps shift your focus away from food when energy stores are sufficient.

The Apnea-Hypopnea Index (AHI) is an imperfect metric for Obstructive Sleep Apnea (OSA) severity because it fails to accurately capture the physiological abnormalities (such as hypoxia and arousal intensity) that drive cardiovascular and neurocognitive outcomes.

If you have been diagnosed with OSA based solely on a low Apnea-Hypopnea Index (AHI) but still experience symptoms like daytime sleepiness, high blood pressure, or poor quality of life, your condition may be under-measured. The standard AHI count often misses the physiological damage caused by oxygen drops or brain arousals. Discuss alternative metrics like 'hypoxic burden' with your sleep specialist to see if your treatment needs align with your symptoms rather than just the event count.

Physiological adaptations to weight loss, including hormonal shifts and reduced energy expenditure, actively favor weight regain, making long-term maintenance difficult without medical intervention.

If you have lost weight, expect your body to fight to regain it through increased hunger and slower metabolism. This is a biological adaptation, not a failure of will. To maintain loss, you likely need to address this physiology directly, potentially through medical interventions or surgery, as behavioral strategies alone are often insufficient against these strong biological drives.

Gastric bypass surgery alters gut hormone levels (low ghrelin, high GLP-1/PYY) in a way that attenuates appetite, contributing to its efficacy as a treatment for obesity.

Gastric bypass surgery works partly by changing gut hormones to reduce appetite (low ghrelin, high GLP-1/PYY). This hormonal shift helps explain why surgery is often more effective than diet/exercise alone for long-term weight loss.

Higher biological age, specifically as measured by DNA methylation estimators (GrimAge, Horvath) and Frailty Index, is independently associated with increased all-cause mortality risk, even after adjusting for chronological age and other biological age measures.

Your chronological age is not your health destiny. Biomarkers like DNA methylation (GrimAge) and Frailty Index provide a more accurate picture of your mortality risk. While you cannot change your birth date, these biological ages reflect your body's current state. High biological age signals elevated risk, but it is modifiable. Focus on interventions that improve physiological function and reduce frailty, as these metrics are strong predictors of longevity. Regular health assessments that go beyond simple age tracking can help identify risks early.

Upstream structural interventions targeting food pricing (taxes and subsidies) are more effective at reducing socioeconomic inequalities in healthy eating than downstream individual-level interventions.

To reduce health inequalities, policymakers should prioritize structural changes like taxes on unhealthy foods and subsidies for healthy foods over individual education campaigns, as the latter often benefit those with higher socioeconomic status more.

Dietary counseling and individual-based education interventions tend to widen socioeconomic inequalities in healthy eating outcomes.

When designing health programs, avoid relying solely on dietary counseling for lower socioeconomic groups. Instead, combine education with structural support to ensure equitable outcomes.

A composite index of three specific IgG glycans (GP6, GP14, GP15) serves as a highly accurate biomarker for chronological age, explaining 58% of age variance, which significantly outperforms telomere length as a predictor of biological aging.

Current blood tests for biological age are improving. This research suggests that analyzing specific sugar structures on antibodies (IgG glycans) provides a much more accurate picture of your biological age than previous methods like telomere counting. While not yet a standard clinical test, it represents a significant leap in our ability to measure aging, potentially allowing for more personalized prevention strategies based on actual biological status rather than just calendar years.

Adiponectin levels decrease in obesity and contribute to cardiovascular risk by failing to provide anti-inflammatory and anti-atherogenic protection to the vessel wall.

Maintaining healthy adiponectin levels through weight management supports blood vessel health. Low levels, common in obesity, remove a natural protective barrier against inflammation and atherosclerosis.

Elevated plasma free fatty acids (FFAs) induce endothelial dysfunction primarily by downregulating the AMPK/PI3K/Akt/eNOS signaling pathway, thereby reducing nitric oxide (NO) production and causing vasoconstriction.

If you have metabolic issues like obesity or type 2 diabetes, your body may have high levels of free fatty acids in your blood. This specifically damages the lining of your blood vessels by blocking the production of nitric oxide, which keeps arteries flexible. Managing metabolic health through diet and exercise can lower these fatty acids and protect your vascular function.

Elevated free fatty acids promote endothelial dysfunction by activating inflammatory pathways (NF-κB) and oxidative stress (NADPH oxidase), leading to reduced nitric oxide availability and increased vasoconstrictors like endothelin-1.

High levels of fatty acids in the blood trigger inflammation and oxidative stress in blood vessel walls. This damage reduces the body's ability to produce nitric oxide (a vessel relaxer) and increases substances that tighten vessels. Reducing metabolic stress helps lower this inflammatory burden.

Inflammaging, characterized by chronic low-grade elevation of proinflammatory cytokines (IL-6, TNF, IL-1), drives age-related functional decline, sarcopenia, and frailty through tissue damage and immune remodelling.

Chronic, low-grade inflammation is a primary driver of muscle loss and frailty in older adults. Managing body composition (reducing visceral fat) and stress (to modulate cortisol/DHEAS ratios) are key strategies to mitigate this inflammatory burden and preserve functional ability.

The cortisol-to-DHEAS ratio is a more accurate predictor of frailty and mortality than cortisol or DHEAS levels alone, as DHEAS antagonizes cortisol's catabolic and immunosuppressive effects.

Focus on maintaining a healthy cortisol-to-DHEAS balance by managing stress and body composition. While DHEA supplementation exists, its benefits are inconsistent, and lifestyle interventions that naturally support hormonal balance are more reliable for preventing frailty.